Asset Publisher
ACA Prevention Copay Waiver Contraceptives Program Summary – Individual Marketplace, Commercial
Policy Number: PH-91187
This program applies to Blue Partner, Commercial, GenPlus, NetResults A series, SourceRx and Health Insurance Marketplace formularies without religious exemptions.
POLICY REVIEW CYCLE
Effective Date |
Date of Origin |
01-01-2025 |
04-01-2023 |
This pharmacy policy is not an authorization, certification, explanation of benefits or a contract. Eligibility and benefits are determined on a case-by-case basis according to the terms of the member’s plan in effect as of the date services are rendered. All pharmacy policies are based on (i) information in FDA approved package inserts (and black box warning, alerts, or other information disseminated by the FDA as applicable); (ii) research of current medical and pharmacy literature; and/or (iii) review of common medical practices in the treatment and diagnosis of disease as of the date hereof. Physicians and other providers are solely responsible for all aspects of medical care and treatment, including the type, quality, and levels of care and treatment.
The purpose of Blue Cross and Blue Shield of Alabama’s pharmacy policies are to provide a guide to coverage. Pharmacy policies are not intended to dictate to physicians how to practice medicine. Physicians should exercise their medical judgment in providing the care they feel is most appropriate for their patients.
Neither this policy, nor the successful adjudication of a pharmacy claim, is guarantee of payment.
CLINICAL RATIONALE
|
The Affordable Care Act (ACA) requires a member-friendly mechanism for waiving the cost share for an alternative recommended product deemed medically necessary by the provider when a health care provider considers the $0 covered product is inappropriate for an individual. Prime Therapeutics offers a standard coverage exception/cost share waiver policy that is applied across all ACA categories. https://www.cms.gov/CCIIO/Resources/Fact-Sheets-and-FAQs/aca_implementation_faqs12.html https://www.cms.gov/CCIIO/Resources/Fact-Sheets-and-FAQs/Downloads/aca_implementation_faqs26.pdf |
OBJECTIVE
The intent of the ACA Prevention Copay Waiver Criteria is to help ensure the copay waiver, when applicable based on the member?s benefit, is applied to the appropriate population as described by Health Resources & Services Administration (HRSA) in support of Women?s Preventive Care.
CLINICAL CRITERIA FOR APPROVAL
Module |
Clinical Criteria for Approval |
Contraceptives ACA Prevention Copay Waiver Criteria |
The requested contraceptive agent will be approved when ALL of the following are met:
Length of Approval: 12 months |